Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Faculty who have authored publication Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma.

NameTitleDepartmentInstitution